Federal HB1806 aims to enhance research and education on triple-negative breast cancer.
Federal HB1806, the Triple-Negative Breast Cancer Research and Education Act of 2025, seeks to improve research and education on triple-negative breast cancer. The bill mandates the Secretary of Health and Human Services to develop and disseminate information to the public and health care providers about the incidence, prevalence, and treatment options for triple-negative breast cancer, particularly focusing on minority women. It also authorizes funding for these activities from fiscal years 2026 through 2031.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.